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Objective:Blunt traumatic thoracic aortic disruption results in pre-hospital death in 80% to 90% of patients. Because of the
significant surgical morbidity and mortality associated with open operative repair, endovascular stent-graft repair has
been investigated. The objective of this study was to evaluate the efficacy of thoracic aortic disruptions treated with
commercially available proximal aortic extension cuffs.
Methods: Nine patients with multiple system trauma (age range, 16-42 years) were seen after motor vehicle accidents
between January 1, 2003, and April 1, 2004. Chest x-ray findings warranted thoracic computed tomography scans, which
revealed disruptions of the thoracic aorta. Aortograms delineated the extent of the aortic injuries and identified a “landing
zone” (neck length range, 1.5-2.0 cm) distal to the subclavian artery but proximal to the tear. The repairs were performed
with AneuRx ( n 8) and Excluder (n  1) proximal aortic extension cuffs. A left femoral artery approach was used in 6
patients, a suprainguinal retroperitoneal approach with an iliac conduit in 2 patients, and direct tunnel in 1 patient. An
Amplatz super-stiff wire was placed in the right axillary artery to enable easy tracking of the endografts, and left brachial
artery access was used for arch arteriography.
Results: In each patient the stent-graft cuff was deployed adjacent to the left subclavian artery, with successful exclusion
of traumatic disruptions verified at intraoperative arteriography and on computed tomographic scans obtained within 48
hours of initial repair. One patient required a second cuff for exclusion of a type I endoleak at the distal attachment site
1 month after the initial endograft repair. There were no procedure-related deaths; 1 patient, however, died of other
injuries.
Conclusions: Stent-graft repair of traumatic thoracic aortic disruptions is technically feasible. Placement of a stiff wire in
the right axillary artery and percutaneous left brachial artery access for arteriography are useful adjuncts during endograft
deployment. Endovascular stent grafts may enable definitive repair or serve as a bridge until the patient is stable enough
to undergo an operation, if necessary. This technique warrants further investigation. (J Vasc Surg 2004;40:1095-1100.)Traumatic rupture of the thoracic aorta is often imme-
diately fatal, and patients who survive frequently have mul-
tiple system injuries, including pulmonary contusions, cra-
nial injuries, multiple fractures, and solid organ injuries.1,2
Operative repair of a thoracic aortic injury in the setting of
these other injuries is associated with significant morbidity
and mortality, and studies3,4 have reported mortality rates
approaching 18% to 28% and paraplegia rates of 2.3%
to14% among survivors. Because of the high risk of imme-
diate surgery, some have advocated delaying intervention
with antihypertensive therapy until the patient is more
stable.5,6 Although this has enabled surgery after recovery
from the acute trauma, complications remain high.
Since initial reports of stent-graft repair of abdominal
and thoracic aneurysm disease, surgeons have considered
this minimally invasive approach for treatment of traumatic
thoracic aortic disruptions.7 Operative complications asso-
ciated with traumatic thoracic aortic disruptions are devas-
tating, and use of a minimally invasive approach seems
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doi:10.1016/j.jvs.2004.09.003ideally suited for treatment of this injury. Anecdotal reports
have been published with small series of patients with
traumatic thoracic aortic disruptions treated with an endo-
vascular approach.8-22 The objective of this study is to
report our initial clinical experience with endoluminal re-
pair of traumatic thoracic aortic disruptions with commer-
cially available devices.
METHODS
Between January 1, 2003, and April 1, 2004, a retro-
spective review of endoluminal repair of traumatic thoracic
aortic disruptions from 3 medical centers in Georgia was
performed. All patients had been in motor vehicle accidents
and sustained severe blunt trauma (Table). All patients
underwent chest x-ray studies. Any suspect x-ray findings
for traumatic thoracic aortic disruption mandated com-
puted tomography (CT). If a traumatic thoracic aortic
disruption was identified, arch aortography was performed
to confirm the CT findings and to further delineate vascular
anatomy. Measurements of the proximal and distal thoracic
aortic diameter and the neck length between the left sub-
clavian artery and the tear were obtained from the CT scan.
Repairs were performed in the operating roomwith the
patient under general anesthesia, with a standby cardiovas-
cular surgery team available. Percutaneous left brachial
artery access was used for aortography. A 5F sheath was
placed in the brachial artery, and a diagnostic catheter was
passed under fluoroscopic guidance to the origin of the left
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standard fashion for stent-graft access, and an 8F sheath was
placed. With use of a selective catheter, access to the right
axillary artery was obtained. An Amplatz (Meditech/
Boston Scientific) super-stiff wire was placed in the ascend-
ing arch or via this catheter into the right axillary artery for
endograft placement (Figs 1 and 2). When necessary, a
suprainguinal incision was made for proximal access to the
larger common iliac artery. Dacron conduits for access were
sutured to the iliac artery in 2 patients. In 1 patient a tunnel
was created between the iliac artery and left femoral artery
in the same manner as for an aortobifemoral bypass. The
stent-graft device was tunneled under the inguinal ligament
for easy direct access to the common iliac artery. This
approach obviated the need for a conduit and provided a
Endoluminal repair of traumatic thoracic aortic disruption
Age
(y) Sex Associated injuries
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Devi
v
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21 M Hemothorax,
multiple
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2 Left c
iliaflatter path for access. The endografts were oversized ap-proximately 10% to 20%, and neck lengths of 1.5 to 2.0 cm
were considered adequate for stent-graft placement. The
stent grafts were deployed in the same fashion as with
abdominal aneurysms. CT scans were obtained within 48
hours after implantation, and follow-up CT scans were
obtained per typical endograft surveillance.
RESULTS
Nine of 10 patients with traumatic thoracic aortic dis-
ruptions (age range, 15-37 years) underwent endoluminal
stent-graft repair between January 1, 2003, and April 1,
2004. One patient in this series was excluded because of
neck diameter too large to accommodate available devices.
All patients were hemodynamically stable at the time of
repair. In 8 patients AneuRx (Medtronic/AVE) aortic ex-
atients with severe blunt trauma
ess
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c artetension cuffs were used, and in 1 patient Excluder (W. L.
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diameter was 25 mm (range, 20-28 mm). Two stent grafts
were used in 7 patients, 3 grafts in 1 patient, and 1 graft in
1 patient. The aortic length from the subclavian artery to
the tear (“landing zone”) averaged 2.3 cm (range, 1.5-4.5
Fig 1. Traumatic thoracic aortic disruption before endovascular
repair. Note that a super-stiff wire has been placed in the right
axillary artery, and a diagnostic catheter through the left brachial
into the arch for aortography.
Fig 2. AneuRx stent graft is easily tracked to a juxta-subclavian
location with use of the axillary artery, and is deployed without
incident.cm). Blood loss in all operations was 100 to 200 mL.Access for deployment varied based on patient body
habitus. Left femoral artery access was attempted for place-
ment in all but 1 patient. In 6 patients deployment from the
femoral exposure was successful, with 1 patient requiring
significant repair of the femoral artery, because of extensive
iatrogenic injury. In 1 patient, a woman 5 feet 3 inches tall,
passage of the device injured the external iliac artery, and
suprainguinal retroperitoneal exposure of the common iliac
artery enabled placement of a conduit to the iliac artery that
was also used for iliofemoral bypass. In 1 patient the device
was not of sufficient length to reach the subclavian artery.
The common iliac artery was exposed through a suprain-
guinal retroperitoneal exposure, and the device was tun-
neled under the inguinal ligament for direct access to the
common iliac artery. Another patient had undergone kid-
ney-pancreas transplantation; consequently, a common il-
iac approach above the pancreas was chosen, to protect the
kidney that was based off the contralateral iliac artery.
After endograft deployment, completion intraoperative
aortograms demonstrated patent grafts without endoleaks
in all patients (Fig 3). Postoperatively, 1 patient had a distal
attachment site type I endoleak, which was detected at CT
a month after repair; a second device was deployed un-
eventfully to seal the endoleak. There were no procedure-
related deaths, paraplegia, renal failure, or other complica-
tions. One patient who had a massive cerebral injury died.
After 1 month, CT scans in the remaining patients showed
no endoleaks. Two patients at 1-year follow-up had mini-
mal evidence of aortic injury and no evidence of endoleak.
Two patients did not undergo CT at 1 year, because of
financial issues. The remaining patients are scheduled for
Fig 3. Repaired traumatic thoracic aortic disruption, with no
endoleak.12-month CT in the coming months.
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Since the initial report byDake et al7 of successful repair
of thoracic aneurysms and traumatic thoracic aortic disrup-
tions with endoluminal stent grafts, several case reports and
small institutional reviews have reproduced their re-
sults.8-22 The results have been promising in comparison
with large surgical series, which report mortality rates of up
to 28% and associated paraplegia rates of up to 14%.3,4
The long-term results of open surgical repair of
traumatic thoracic aortic disruptions make this proce-
dure the gold standard. The attendant morbidity and
mortality of this operation, however, have spurred inter-
est in less invasive and less traumatic methods of repair.
Since Parodi et al23 first reported the use of an endolu-
minal stent graft for repair of abdominal aortic aneu-
rysms, use of the endoluminal stent-graft procedure has
expanded rapidly. Its use for repair of traumatic thoracic
aortic disruptions eliminates the need for extensive sur-
gery with the attendant hazards of anticoagulation,
single-lung ventilation, aortic cross-clamping, and tho-
racotomy.
The primary difficulties encountered with commer-
cially available endograft devices have been related to de-
livery system length and size. The AneuRx, Zenith (Cook
Inc), and Excluder aortic cuffs are designed for delivery to
the infrarenal aorta. This allows for only 55 cm of length in
the AneuRx and Zenith delivery devices and 61 cm of
length in the Excluder delivery device to reach the left
subclavian artery. These device lengths are usually sufficient
for delivery to a juxtra-subclavian artery landing zone;
however, a retroperitoneal conduit and insertion through
the iliac artery may be needed. In our experience, patients
less than 6 feet tall can be treated with the commercially
available devices through a femoral approach. In taller
patients, it may be necessary to use an iliac conduit or an
easier tunneled approach under the inguinal ligament for
direct iliac access. For more proximal landing, that is, in the
junction between the left common carotid artery and the
left subclavian artery, these devices would require higher
exposure in the common iliac artery. With the coming
release of endoluminal devices specifically designed for
thoracic aortic endografting, this problem will be obviated.
Another difficulty encountered with currently available
devices is the size of the devices (18F-22F) relative to the
access artery. These devices are fairly large, and in young
patients the femoral artery may not be large enough to
accommodate them. Therefore we approach the iliac artery
through a suprainguinal approach, and create an “inguinal
tunnel” for device access. Although improvements in stent-
graft designmay resolve the size problem, the current thoracic
devices in trial use are as large or larger than the commercially
available abdominal aortic cuff delivery systems.
Most traumatic thoracic transactions occur distal to the
left subclavian artery. The distance from the subclavian
artery landing zone to the tear is variable, with a recent
study12 citing amean length of 28.5mm, which is similar to
our mean length of 22.5 mm. However, a review of trau-matic thoracic angiograms cited a mean length of 14.9 mm
along the greater curve of the aorta, and 5.8 mm along the
lesser curve.22 Current recommendations for thoracic an-
eurysm repair require a proximal landing zone of 10 to 20
mm.15 These guidelines come from experience with the
Talent and Excluder TAG grafts). Most of these patients
underwent thoracic aneurysm repair, and an aneurysmal
thoracic aorta may not correlate with the necessary landing
zone for traumatic thoracic aortic disruption repair, espe-
cially in younger patients who have nondiseased aortas that
may enable easier seal, better fixation, and decreased chance
for migration. Furthermore, the nature of the injury may
result in a different healing process around the stent graft
that would not necessitate 20 mm for fixation and seal. In
fact, on the 2 CT scans obtained at 1 year there wasminimal
evidence of the initial injury and no migration. If there is
not an adequate landing zone, the subclavian artery can be
covered and a carotid-subclavian bypass performed if upper
extremity ischemia develops. This approach has been advo-
cated, and can be used in a short neck landing zone.17 As
experience with traumatic thoracic aortic disruption in-
creases and devices for the arch become available, the
necessary length and anatomic location of the landing zone
will be more adequately delineated.
Two technical maneuvers simplified endograft deploy-
ment. The first was placement of an Amplatz super-stiff
wire into the right axillary artery from the access artery. This
allowed excellent tracking of the device to the level of the
left subclavian artery. The second maneuver was placement
of a percutaneous left brachial artery sheath and diagnostic
catheter, which allowed continuous aortography during
and after deployment of the device. It also served as a
marker of the left subclavian artery.
Traumatic thoracic disruption is often associated with
multiple system injuries. Many patients are unstable, mak-
ing care difficult. Typically, hemodynamic instability is
related to other processes, such as intraabdominal injuries
or orthopedic injuries, but not the traumatic thoracic aortic
disruption. Despite this, the validity of placing an endograft
in an unstable patient is questioned. Certainly any device
used in an investigational manner will lead to extra caution;
yet it may be that stent grafts are the best treatment in
patients who can be managed with permissive hypotension.
If, however, the patient is truly unstable as a result of the
disruption, it is hard to justify anything short of immediate
surgical control of the thoracic aorta.
Patients with trauma are typically difficult to follow up
after discharge from the hospital. This issue presents an
ethical dilemma in repair of traumatic thoracic aortic dis-
ruptions with stent grafts. Should treatment be withheld
because of the possibility of losing the patient to follow-up?
Postoperative imaging should include CT scans at 1 and 12
months for the first year, and then yearly. Strategies for
tracking these patients will need to be developed, similar to
those used for patients with abdominal aortic stent grafts,
that also takes into consideration the instability of this
population, and their often poor insurance status and in-
ability to pay for CT scans. The importance of postopera-
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devices are not specifically constructed for this indication,
the long-term durability of this method of repair is truly
unknown, and the effect of an oversized stent graft in a
young person’s aorta is yet to be determined.
CONCLUSIONS
Stent-graft repair of traumatic thoracic aortic disrup-
tions is technically feasible. Placement of a stiff wire into the
right axillary artery and left brachial access for aortography
are useful adjuncts to facilitate deployment. Endovascular
stent grafts may enable definitive repair or serve as a bridge
until the patient is stable enough to undergo open opera-
tive repair, if necessary. This technique warrants further
investigation.
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Dr Linda Harris (Buffalo, NY). Endovascular interventions,
as we’ve heard earlier today, have certainly improved outcomes in
ruptured aneurysms, and are likely to see a similar benefit in
patients who have traumatic vascular injuries.
Dr Wellons and colleagues evaluated 9 patients over approxi-
mately 1 year who underwent stent-graft repair of traumatic tho-
racic aortic transections using commercially available aortic exten-
sion cuffs. They report success in the 9 patients, but do not really
give us a great deal of outcome information or follow-up.
They do give 2 technical suggestions to increase ease of
deployment, which include use of the Amplatz super-stiff wire in
the right axillary artery and percutaneous placement of a left
brachial sheath for a diagnostic marker.
I have several questions for the authors. First of all, during this
period howmany patients with multisystem trauma were evaluated
for thoracic aortic injuries, and how many patients were refused
this type of technology and treated in a more conventional fashion,What are your outcomes? You state transection was repaired
with 2 stent grafts in 7 patients, 3 grafts in 1, and 2 grafts in the
remaining patients. Did the patients survive? Did any of them
require open repair after bridge therapy? You mentioned this as a
possible bridge to open repair, but never stated that any of these
patients required bridge therapy.
What is your long-term and short-term follow-up on the
stability and lack of migration in these patients? Along these lines,
one of the problems with trauma patients is that they don’t tend to
follow up. And with endovascular repair, one of our concerns has
been long-term outcomes. Is there an ethical issue in which these
patients should be converted after they have been stabilized to an
open repair? These patients are young, or many of them may be
young, they may have dilatation of the aorta as they grow older,
when we may not follow up with them, and they may come in
later with a recurrent rupture because the grafts have
migrated.
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deployment? You did mention difficulty with graft access link. Do
you have any recommendations based on patient size, gender, and
artery size, so that we don’t waste time using a femoral artery
approach in a patient when it’s not going to be successful.
Dr Eric Wellons (Atlanta, Ga). During the period of the
study there was only 1 patient with a thoracic tear who was not
offered this treatment option, because of a short neck. This patient
was treated with immediate open repair.
There was only 1 death in the group of patients treated, and
this was related to other injuries suffered in the accident. As all
repairs were considered satisfactory at the time of operation and
latest follow-up, to a year, there has been no need for bridge
therapy.
The latest follow-up data we have on these patients is 1 year.
At this juncture there is no evidence of migration, and the repairs
look excellent. The problem regarding maintaining adequate fol-
low-up in trauma patients is a difficult one, and I am afraid I do not
have a good solution. Is this an ethical dilemma? Yes. However, the
potential benefits of stent-graft repair versus open repair seem to
outweigh the follow-up difficulties.
Regarding suggestions for access, we have used CT scan
measurements, marker catheters, and simply placing the device on
the patient to get an idea of the access point. While this has helped,
it has not provided definitive information, and higher access has
had to be obtained after femoral cutdowns. Furthermore, the
femoral and external iliac size has been an issue that also has
required higher access. I don’t think there are any particular
guidelines that we can give you, because we do not have enough
experience to say which patient is suitable or not.
Dr D. Bhaskar Rao (Wilmington, Del). One question: Is
there is good literature from trauma and other publications that
CT scans are very reliable for sizing or for diagnosis of traumatic
transection. And with these patients in ICU, and sometimes
they’re unstable, do they really need preoperative angiography?
Second question: What is the timing between the trauma and
your intervention? And how do you manage preoperative in terms
of hypotension?
Third question: Do you give heparin? Some of these patients
may have a cranial injury that may contraindicate heparin.
Dr Wellons. Your point regarding aortography is very accu-
rate. As you mentioned, much of the planning can be done based
on CT scans. In our institution the trauma service typically obtains
a CT scan and consults radiology immediately for an aortogram
before we become involved.
In all of these cases the patients have been stable or relatively
stable. In fact, most patients have been normotensive or hyperten-
sive. This has allowed us to perform the operations in a timely and
deliberate fashion, without significant haste or delay.
Regarding heparin, we have been selective with use of heparin.
If there are not any intracranial injuries, we’ve used low doses of
heparin. Is it necessary or not? The operations go pretty quick once
you obtain access, and heparin has not been thought essential.
Dr Manish Mehta (Albany, NY). Your paper truly highlights
the adjunctive procedures we can do to solve difficult problems
endovascularly.
On a more a technical note, I think the problems that you
might have had in deploying stent grafts across the arch, especially
high arches, is that there is bending of the AneuRx device, not
necessarily because of the arch, but I think it’s the wire. I think they
are stiffer wires than the Amplatz. And especially for thoracic
procedures, the Lundquist is probably a better choice. We use that
routinely. And even in much more difficult arches, we have not
found that problem.
Dr Wellons. Certainly the Lundquist wire may be the answer
to our initial problems. However, we have had good success with
the axillary wire, and it should be considered in difficult cases.
Dr Christian D. Schunn (Morgantown, WVa). I have 2
questions: Given equal size, which of the 3 cuff extenders wouldyou prefer? How do you cover your back legally in terms of
off-label use of these cuffs?
Dr Wellons. Of the 3 stent-graft cuffs, I believe they all will
work well in fixing the tear. In discussions with Dr Milner, the
Gore Excluder seems to have the benefit of tip flexibility and
additional length (6 cm), which may make it more usable in taller
patients. The AneuRx device, though, has worked well, and it
would be hard to say which is the best. I do not have experience
with the Zenith graft.
Dr Schunn.Have you seen an age group in which the natural
size of the aorta is too big to prevent you from using something
that’s not designed to be big enough for this?
Dr Wellons. One person had an aorta that was too big for
available devices.
I have not talked about the medical-legal issues. We discuss
the options with the patient’s family, present the historic data
regarding open thoracic repair, and tell them this is an investiga-
tional off-label use of an FDA-approved device, with the potential
risks and benefits and the need for long-term follow-up. Everybody
has been happy, because outcomes have been fantastic. But I don’t
know what will happen when we have a poor outcome.
DrRonaldM. Fairman (Philadelphia, Pa).My interest in this
has sort of waxed and waned over the last couple of years. The early
results of treating these patients endovascularly had about a 50%
mortality, so I think your results are just wonderful in the short
term.
Just 2 points. I’d be interested to hear, perhaps, what Bill Flinn
has to say about this. But at Penn we have a very big trauma service
also, and these patients get flown in all the time, and they fre-
quently have intracranial bleeding and other injuries. Our trauma
surgeons believe that if a patient arrives at Penn with a stable
transection, then actually the natural history of that, over the first
few months, is pretty benign. So if they arrive and they’re stable,
and they’re not symptomatic from the transection, their enthusi-
asm for me treating that early is not very high. And you may want
to comment, Bill, about what the people at Maryland do.
The other issue is, my understanding is that virtually all of
these lesions tend to occur within a few millimeters of the left
subclavian. And therefore I wonder about the stability of your
proximal attachment site, certainly to a year or 2. I almost wonder,
if you’re going to treat these patients with a thoracic stent graft,
whether you have to always do something with the left subclavian
in order to get your 20-mm or 30-mm proximal seal.
DrWilliamR. Flinn (Baltimore,Md). It really sounds like we
have just about the same uncertain relationship with the trauma
service at Maryland as you do in your situation. But again, our
trauma surgeons, the ones who are the most forthright, and that’s
certainly a variable, do manage stable patients conservatively. For
reasons that perhaps are politically clear but therapeutically unclear
to me, they haven’t developed any enthusiasm, or a very, very
modest enthusiasm, for going out on the edge on some of these
things.
Dr Wellons. Our trauma surgeons are very happy that we’re
doing this, and the thoracic surgeons are even happier, because of
the poor results they’ve had in the past.
The issue with regard to neck fixation and length is an inter-
esting one to me. These are different patients than those with
aneurysmal disease, and I am not sure the same rules should apply.
Theoretically, the proximal and distal aorta is smaller and relatively
healthy. This may mean that a shorter landing zone, say 10 mm, is
sufficient to ensure seal. Furthermore, one would expect less
migration if landing in a normal distal aorta. Another question is,
how will the aortic tear heal around this stent graft? It may be that
the healing will be relatively quick, with later complications being
more from in-stent stenosis than degeneration of the aorta. Be-
cause of these issues, I think it’s reasonable to be more aggressive
with these patients, especially a young person with a significant
chance of paraplegia.
